Загрузка...
Managing drug–drug interactions with new direct‐acting antiviral agents in chronic hepatitis C
Several direct‐acting antiviral agents (DAAs) have marketing authorization in Europe and in the USA and have changed the landscape of hepatitis C treatment: each DAA has its own metabolism and drug–drug interactions (DDIs), and managing them is a challenge. To compile the pharmacokinetics and DDI da...
Сохранить в:
| Опубликовано в: : | Br J Clin Pharmacol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237698/ https://ncbi.nlm.nih.gov/pubmed/27530469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13095 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|